Micro-immunotherapy is an innovative immunomodulation therapy that supports re-balancing of the immune response. Micro-immunotherapy therefore utilises low-dose, low-concentration immune messenger therapy support, in a specific sequence to optimise the re-balancing process.
Colabs supports practitioners with MeGeMIT testing to support decision-making for a client’s Micro-immunotherapy Protocol.
